You Position: Home > Paper
Intra-operative mitomycin C for nonpenetrating filtering surgery in treatment of open angle glaucoma: a systematic review and meta-analysis
( views:200, downloads:0 )
- Author:
- No author available
- Journal Title:
- Academic Journal of Second Military Medical University
- Issue:
- 9
- DOI:
- 10.3724/SP.J.1008.2012.01006
- Key Word:
- 开角型青光眼;非穿透性小梁手术;丝裂霉素C;meta分析
Abstract： 目的 评价非穿透性小梁手术联合使用丝裂霉素C对治疗开角型青光眼患者的疗效及耐受性的差异.方法 检索MEDLINE、EMBASE、中国生物医学文献数据库、Cochrane图书馆,获得以往发表的相关论文,经筛选后共有8项临床对照试验纳入meta分析.比较非穿透性小梁手术联合使用与未使用丝裂霉素C的眼压下降百分比、治疗完全成功率、治疗总成功率和并发症等指标.使用RevMan 5.0软件进行统计分析.结果 术后6、12、24、36个月非穿透性小梁手术联合使用丝裂霉素C组与单纯非穿透性小梁手术组眼压下降百分比的加权均数差分别为5.24％(95％CI,-3.24～13.72)、8.31％(95％CI,4.33～12.30)、9.56％(95％CI,4.88～14.24)、14.45％(95％CI,9.02～19.88),除术后6个月外的其余各个时间点两组之间差异均存在统计学意义(P＜0.05).非穿透性小梁手术联合使用丝裂霉素C组的治疗完全成功率较单纯非穿透性小梁手术组增加,治疗完全成功率的合并风险差在术后6、12、24、36个月分别为1.16(95％CI,1.05～1.27)、1.20(95％CI,1.05～1.38)、1.30(95％CI,1.05～1.61)、1.36(95％CI,1.06～1.73),各个时间点两组之间差异均存在统计学意义(P＜0.05).术中应用丝裂霉素C未出现与药物相关的并发症.结论 联合应用丝裂霉素C可以改善非穿透性小梁手术的疗效,而且耐受性良好.
- [1]王竫华,贺春梅,王大博,等.应用低浓度丝裂霉素C的非穿透性小梁切除术[J].2005,(3).
- [2]钟白丽,侯宝杰,吴海洋,等.冰冻羊膜在非穿透小梁术中的应用[J].2007,(7).
- [3]Rebecca DerSimonian,Nan Laird.Meta-analysis in clinical trials[J].1986,7(3).
- [4]Anand N,Anand S.Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.[J].2008,22(8).
- [5]Li Y,Wei RL,Cai JP,etc.Efficacy and tolerability of nonpenetrating filtering surgery with and without implant in treatment of open angle glaucoma: a quantitative evaluation of the evidence.[J].2009,18(3).
- [6]M, Wilkins,A, Indar,R, Wormald.Intra-operative mitomycin C for glaucoma surgery.[J].2005,(4).
- [7]Atherley C,Anand N.Deep sclerectomy augmented with mitomycin C.[J].2005,19(4).
- [8]Tzanakis N,Kozobolis VP,Christodoulakis EV,etc.Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.[J].2002,11(4).
- [9]Mendrinos E,Mermoud A,Shaarawy T.Nonpenetrating glaucoma surgery.[J].2008,53(6).
- [10]Sadetzki S,Geyer O,Anisimova S,etc.Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C.[J].2004,35(1).
- [11]Alp MN,Yarangumeli A,Kural G,etc.Viscocanalostomy with Mitomycin-C: A preliminary study.[J].2005,15(2).
- [12]Constable PH,Khaw PT,Daniels JT,etc.Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts.[J].1998,39(2).
- [13]J C, Javitt.When does the failure to find a difference mean that there is none?[J].1989,107.
- [14]Hondur A,Onol M,Hasanreisoglu B.Nonpenetrating glaucoma surgery: meta-analysis of recent results.[J].2008,17(2).
- [15]Mielke C,Dawda VK,Anand N.Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in west Africa.[J].2006,90(3).
- [16]Rausch, JR,Kelley, K,Maxwell, SE.Sample size planning for statistical power and accuracy in parameter estimation[J].2008,59.
- [17]T J, Bergstrom,W S, Wilkinson,G L, Skuta,etc.The effects of subconjunctival mitomycin-C on glaucoma filtration surgery in rabbits.[J].1991,109.
- [18]Chang LH,Akbar AN,Daniels JT,etc.Apoptosis gene expression and death receptor signaling in mitomycin-C-treated human tenon capsule fibroblasts.[J].2002,43(3).